摘要
口服新达罗胶囊治疗支气管-肺感染108例,临床总有效率为81.5%,细菌清除率为91.8%,不良反应发生率为5.5%。结果表明:新达罗胶囊是一种新型高效杀菌剂,对支气管-肺感染常见致病菌有较强的杀菌作用,尤其适用于阻塞性肺疾病演变成肺心病、心肺功能不全的老年病例,疗效肯定。
Cefaclor capsules were given to 108 patients with broncho lung infections,a total effective rate of 81.5% and a bacterium clearance rate of 91.8% were obtained,with a incidence of side effect of 5.5%.From the results obtained it can be concluded that cefaclor is a promising agent for treatment of broncho lung infections especially for elder patients with obstructive lung disease.
出处
《中国新药杂志》
CAS
CSCD
1996年第4期286-287,共2页
Chinese Journal of New Drugs